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ABSTRACT 
Conclusion: Extensive bone erosion correlated with a worse prognosis of the squamous 
cell carcinoma (SCC) of the temporal bone but extensive soft tissue involvement did not 
correlate with prognosis in this study.  Resectability of the tumor seems to be major 
prognostic factors of temporal bone SCC.  
Objective: Prognostic factors for SCC of the temporal bone were evaluated regarding 
initial clinical symptoms and radiographic imaging. 
Methods: Clinical symptoms of the patients with primary SCC of the external auditory 
canal (EAC) or middle ear (ME) were reviewed based on medical records. Correlation 
of clinical symptoms and cancer severity staging using the modified Pittsburgh 
classification was analyzed, along with disease-specific survival (DSS). 
Results: Sixteen patients with primary SCC of the EAC (n=13) or ME (n=3) were 
included in the study population. Disease-specific survival was not influenced by 
whether a hearing disturbance or otalgia was noted at the first medical examination.  
Extended bone involvement identified with imaging studies significantly correlated with 
worse prognosis (p<0.05).  Prognoses of patients without extensive bone erosion were 
well and extensive (≥0.5 cm) soft tissue involvement did not correlate with prognosis in 
this study.  Prognoses of patients with insufficient bone resection or no surgery were 
significantly poor (p<0.01).  
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Squamous cell carcinoma (SCC) is the most frequent primary malignant tumor of the 
temporal bone, but the incidence is as rare as <0.2% of all tumors of the head and 
neck.[1] It is a rare, but threateningly aggressive, tumor with poor prognosis.  Many 
publications have tried to evaluate survival in this aggressive disease, but patient 
numbers are limited (ranging from 10 to 39 patients, with most <30 patients), and 
surveillance periods are too long (ranging from 10 to 37 years, with most >15 years), 
possibly due to the rarity of this disease.[1-9] The quality of imaging studies (Computed 
tomography (CT) and magnetic resonance imaging (MRI)) has improved dramatically 
over time, and the accuracy of diagnosis of this disease is influenced by the quality of 
imaging. Similar reports contain many patients, but they are multi-institutional 
retrospective studies, with the surgical procedure and the surgeon different at each 
institution and surveillance periods are too long (>20 years).[10, 11] By chance, we had 
experience with 16 cases of primary SCC of the temporal bone over 6 years (from 2001 
to 2006). Because it was a brief surveillance period, the qualities of the imaging studies 
were similar and the same surgeon performed all surgical procedures. The University of 
Pittsburgh staging system[12] is most common classification tool for temporal bone 
SCC, and we followed the modified version of this classification for these patients[1]. 
Although many previous reports conclude that long-term prognosis of temporal bone 
SCC depends mainly on staging and primary treatment[1, 4, 5], there is no universally 
accepted staging system for temporal bone SCC. Due to the limited database for this 
tumor type, it has been difficult to determine any correlation between the clinical 
conditions, clinical symptoms and the extent of the lesion, and prognosis. In the present 
study, we try to evaluate the prognostic factors associated with the survival rate for SCC 
of the temporal bone.   
MATERIALS AND METHODS 
A retrospective case review was performed on all patients receiving treatment of SCC of 
the external auditory canal or middle ear at Kanazawa University Hospital (Kanazawa, 
Japan) from 2001 to 2006. The observation duration for survival was defined as ≥ 30 
months after diagnosis. Clinical symptoms before treatment were identified based on 
patient medical records. The extent of the lesion was estimated for all patients through 
imaging study and physical examination findings. Computed tomography and MRI 
were routinely conducted and positron emission tomography (PET) was carried out in 
some cases.  Bone invasion and soft tissue involvement were determined by CT scan 
and MRI, respectively.  Regional lymph node swelling and distant metastases were 
distinguished by PET scan.  Tumors of the external auditory canal (EAC) and middle 
ear (ME) were staged according to the University of Pittsburgh staging system 
(Moody’s modified) for malignancies of the EAC (for definitions, see Table 1).[1, 12] 
All tumors of the ME were classified into T4 stage because tumors were eroding deep 
parts of the temporal bone.  
 The surgical resection we performed most often was lateral temporal bone 
resection (LTBR) (n=10). In cases of LTBR, the bony and cartilaginous portions of the 
EAC, including the anterior bony EAC, were removed en bloc. All surgical procedures 
were performed by the same surgeon (Ito.M). Lateral temporal bone resection was 
performed combined with radiation therapy for the tumors that remained lateral to the 
tympanic membrane. All patients with T2 and T3 diseases received LTBR. Lateral 
temporal bone resection was also performed for some patients with T1 and T4 disease; 
one T1 case (No.2) had tumor located in the deep part of EAC, two T4 cases (No.10 and 
11) had limited external auditory canal bony erosion but had extensive (≥0.5 cm) soft 
tissue involvement, and other two T4 cases (No.12 and 13) required extensive gross 
tumor removal.  
CT, MRI, and/or PET were routinely carried out every 6 months for up to 3 
years after treatment. Because scar tissue after surgery or irradiation was often hard to 
differentiate from recurrent SCC, we distinguished them by using size enlargement of a 
space-occupying lesion. Clinical outcomes included the occurrence and timing of any 
recurrence (local, regional lymph node, or distant metastasis), the last follow-up date, 
and death. Disease-specific survival (DSS) rates were determined using the 
Kaplan-Meier method and the log-rank test was applied to compare survival outcomes. 
The correlation of clinical symptoms before treatment and T staging in the Pittsburgh 
classification with DSS was analyzed statistically. P-values <0.05 were considered 
statistically significant. 
RESULTS 
The medical records for a total of 16 patients with the primary SCC of the EAC (n=13) 
and ME (n=3) were reviewed retrospectively (Table 2).  There were 7 males and 9 
females, ranging in age from 41 to 83 years, and the mean age at first visit for the 
population was 64 ± 13.8 years. The distribution of T stages for primary tumors was T1: 
3, T2: 2, T3: 3, and T4: 8. All ME diseases (Nos.9, 14, 15) were classified into T4 stage 
in the present study. One patient (No.12) in the T4 group had regional lymph node 
involvement. The most common presenting symptoms were otorrhea (15 patients: 
93.7%), otalgia (12 patients: 75.0%), and hearing disturbance (10 patients: 62.5%). 
Disease-specific survival was not influenced by whether otalgia or hearing disturbance 
(HD) were present at the time of the diagnosis (Figures 1 and 2).  
One patients with T1 tumors received LTBR alone because the tumor was 
located in the deep part of the EAC. Two other T1 patients received local canal wall 
resection (LCR). Ten patients (one T1, all T2 and T3, and four T4) received LTBR. 
Three patients with T4 disease received chemo-radiation therapy alone because tumors 
showed extensive dura matter and major vessels invasions. Eleven patients received 
radiation therapy combined with surgery. One patient (No.5, T2) received subtotal 
temporal bone resection (STBR) after postoperative radiotherapy because of local tumor 
recurrence. Another one patient (No.9, T4) received STBR. Six patients in the T4 group 
and all patients in the T3 group showed extensive bone involvement, including T4 with 
bone erosion of the deep temporal bone and T3 with apparent bone erosion of the 
external auditory canal and/or tumor involving the middle ear cavity. Extensive bone 
involvement significantly correlated with a worse prognosis (Figure 3, p<0.05). There 
were three patients (Nos.14 to 16) with dural involvement and four patients (Nos.13 to 
16) with major vessels invasion. The prognoses of all these patients with erosion of the 
deep temporal bone were quite poor. On the other hand, other two patients in the T4 
group (No.10 and 11) showed extensive (≥0.5 cm) soft tissue involvement but limited 
bone erosion and the prognoses of these two T4 cases (No.10 and 11) were quite well. 
Extensive (≥0.5 cm) soft tissue involvement (four T4 cases) did not correlate with a 
worse prognosis in this study (Figure 4). Disease-specific survival comparing patients in 
the early stage group (T1-T2) with the advanced stage group (T3-T4) are shown in 
Figure 5. Kaplan-Meier analysis demonstrated that there was no statistically significant 
difference in DSS for patients with early stage versus advanced stage diagnoses. 
Facial nerve paralysis was found in 3 patients (Nos.14, 15 and 16) and these 
three patients were classified into T4 because of extensive bone involvement with 
Pittsburgh staging system; i.e. dural involvement and major vessels invasion, and their 
prognoses were quite poor, with survival times not longer than 12 months. In addition to 
the facial nerve paralysis, bone destruction of the fallopian canal was detected in three 
patients who did not show facial paralysis (No. 8 in T3 and Nos. 12 and 13 in T4). We 
performed LTBR for these three patients, one male patient (No.8) received additional 
facial nerve resection and other two female patients (No.12 and 13) refused resection of 
the facial nerve, and surgical margins of these three patients were positive. Then these 
patients received post-operative radiation therapy. They showed facial paralysis at the 
time of local recurrences and their survival times were not longer than 28 months. 
Within these three patients, one patient (No. 8 in T3) represented tumor eroding the 
osseous external auditory canal (full-thickness) and the fallopian canal then we 
performed LTBR. Unfortunately the pathological diagnosis after surgery showed tumor 
invasion into the mastoid and the deep temporal bone. One patient (No. 12 in T4) 
represented tumor eroding the jugular foramen and we recommended STBR but she 
refused resection of the facial nerve and STBR. It might be better to choose STBR 
instead of LTBR for these two patients. Another one patient (No. 13) showed carotid 
canal bone involvement so that we did not recommend surgery but patient asked us 
gross tumor removal before radiotherapy.  
In contrast, there were other four advanced stage patients (Nos. 6, 7 in T3 and 
Nos. 10, 11 in T4) without extensive bone destruction of the deep temporal bone. They 
received complete LTBR and surgical margins were negative. The prognoses of these 
four patients were quite well, no disease over 32 months. Another one patient in ME 
tumor (No. 9 in T4) received STBR and her prognosis was well. Among the total 16 
patients, 7 patients died of disease. Six patients underwent insufficient / no surgery and 
all of them died of disease. On the other hand, only one patient died of disease among 
10 patients who underwent total tumor removal (Figure 6, p<0.01). Resectability of the 
tumor was strongly related to the prognosis in this study. 
DISCUSSION 
Management of SCC of the temporal bone remains challenging for ear and skull base 
surgeons due to the proximity of the dura mater and the nearby neural and vascular 
structures. These rare malignant tumors involve the anatomically complicated temporal 
bone and the lack of universally accepted cancer staging system makes treatment 
planning challenging. Clearly, surgery combined with or without radiotherapy is widely 
accepted as the standard of treatment and previous reports found that radiotherapy alone 
or salvage surgery after radiotherapy had depressingly poor prognoses.[1, 4, 5] However, 
the results of these previous studies are limited by the small number of patients involved 
and too long periods of time required to collect these cases. Long periods of 
surveillance resulted in different qualities in imaging studies used for staging and 
different surgical techniques. Many factors make it difficult to get clear information 
from the literature regarding prognosis and optional treatment of temporal bone SCC. 
We report here 16 cases of primary SCC of the temporal bone within a brief 
surveillance period (6-years). The quality of the imaging studies was similar and the 
same surgeon performed all surgical procedures in this study.  
The University of Pittsburgh staging system for primary SCC of the external 
auditory canal was proposed in 1990 as a straightforward and precise system for 
classifying disease before treatment.[12] It is now the most common classification 
system and endorsed by many reports in the literature.[1-8, 10] Although extensive 
(≥0.5 cm) soft tissue involvement was considered as T4 disease in Pittsburgh staging 
system, one of the main finding in the present study was that extensive bone 
involvement significantly correlated with a worse prognosis but extensive (≥0.5 cm) 
soft tissue involvement did not correlate with prognosis. Radiotherapy combined with 
surgery may be effective in cases with such soft tissue diseases. We decide the surgical 
procedure according to the expansion of bone involvement. Our treatment strategy of 
the surgical procedure for the temporal bone SCC is followings; LCR for T1 disease 
except tumor located in the deep part of the EAC, LTBR for T1 with tumor located in 
the deep part of the EAC, all T2 diseases and T3 with tumor eroding the osseous 
external auditory canal, STBR for T3 disease with tumor involving middle ear and/or 
mastoid and a part of T4 disease such as restricted bone involvement of medial wall of 
middle ear or jugular foramen. T4 disease with extensive soft tissue involvement but 
limited bone erosion is treated as same as above treatment strategy according to the 
bone involvement. 
Although many of the previous reports concluded that early stage group 
(T1-2) had better survival and recurrence outcome compare to advanced stage group 
(T3-4), some reports failed to find statistically significant differences between these two 
groups.[6] In the present study, there was no statistically significant difference between 
these two groups. The lack of significant differences in our population was probably due 
to the small number of patients in the early stage group (n=5), but another possibility 
was due to the good prognoses of two T4 cases (No.10 and 11) with extensive (≥0.5 cm) 
soft tissue involvement but limited external auditory canal bony erosion, they were alive 
without disease. Moore et al also failed to find significant difference between early 
stage group (T1-2) and advanced stage group (T3-4), with the majority of their T4 cases 
being classified as such because of extensive soft tissue involvement.[6] Because 
extensive bone erosion, but not extensive soft tissue involvement, significantly 
correlated with a worse prognosis in this study, further investigations to elucidate a 
universal staging system must be continued.  
The University of Pittsburgh staging system was modified in 2000 to reflect 
the opinion that facial nerve paralysis indicated a prognosis comparable to that of T4 
disease.[1] Although this modification has not been evaluated in some other studies[2, 
8], our data confirm its utility in the present study. The prognoses of the three patients 
(No.14, 15 and 16) who presented with facial nerve paralysis before treatment were 
quite poor, and their survival times were no longer than 12 months. Our results support 
the accuracy of the Moody’s modification[1] of the University Pittsburgh staging 
system for SCC of the temporal bone. In addition to the facial nerve paralysis, other 
three patients (No.8, 12 and 13) with bone destruction of the fallopian canal in the 
imaging studies before treatment also showed poor prognosis, their survival times were 
no longer than 28 months. These three patients underwent insufficient bone resections. 
Within these three patients, two patients (Nos. 8 and 12) might have had better 
prognosis if they received STBR instead of LTBR. Six in the 7 patients who died of 
disease underwent insufficient / no surgery. On the other hand, only one patient died of 
disease among 10 patients who underwent total tumor removal.  Complete resection of 
the tumor might be most important prognostic factor for the treatment of the temporal 
bone SCC.  
CONCLUSIONS 
Extensive bone erosion significantly correlated with worse prognosis but extensive soft 
tissue involvement did not correlate with prognosis in this study. The modification of 
the University of Pittsburgh staging system[1] to include facial nerve paralysis as a 
prognostic factor of T4 stage represents an acceptable staging system for primary SCC 
of the temporal bone. The prognoses for patients with facial nerve paralysis at the first 
medical examination are quite poor and comparable to that of T4 disease. The 
prognoses for patients with insufficient resection are also quite poor. Complete resection 
of the tumor seems to be one of the most important prognostic factors of the temporal 
bone SCC.   
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FIGURE LEGENDS and TABLE 
Figure 1:  
Kaplan-Meier survival curves of DSS for the patients with or without otalgia. 
 
Figure 2:  
Kaplan-Meier survival curves of DSS for the patients with or without hearing 
disturbance. 
 
Figure 3:  
Kaplan-Meier survival curves of DSS for patients with or without extensive bone 
involvement. A statistically significant increase was seen in OS and DSS of those 
patients with extensive bone involvement (P<0.05).  
 
Figure 4:  
Kaplan-Meier survival curves of DSS for patients with or without extensive (≥0.5 cm) 
soft tissue involvement. 
 Figure 5:  
Kaplan-Meier survival curves of DSS for early stage group (T1-2) and advanced stage 
group (T3-4). 
 
Figure 6:  
Kaplan-Meier survival curves of DSS for complete tumor removal cases and 
insufficient / no surgery cases. 
 
Table 1: 




Summary of 16 patients with Squamous Cell Carcinoma of the temporal bone 
Table 1. University of Pittsburgh staging system (Moody’s modified) for Squamous 
Cell Carcinoma of the external auditory canal 
 
T status 
T1: tumor limited to the external auditory canal without bony erosion or evidence of 
soft tissue involvement 
T2: tumor with limited external auditory canal bony erosion (not full-thickness), or 
limited (<0.5 cm) soft tissue involvement 
T3: tumor eroding the osseous external auditory canal (full-thickness) with limited 
(<0.5 cm) soft tissue involvement, or tumor involving middle ear and/or mastoid 
T4: tumor eroding the cochlea, petrous apex, medial wall of middle ear, carotid 
canal, jugular foramen, or dura, or with extensive (≥0.5 cm) soft tissue 
involvement, such as involvement of temporomandibular joint or styloid process, 
or evidence of facial paresis 
N status 
Lymph node involvement is a poor prognostic sign; any node involvement should 
automatically be considered as advanced stage, ie, T1N1 = stage III and T2, 3, 4 N1 
= stage IV 
M status 
Distant metastases indicate a very poor prognosis and should be considered as stage 
IV disease 
 
In the absence of metastastic lymph nodes or distant metastases, T status of the tumor 
defines the clinical stage 
















1 EAC 79 M T1N0 No No No S+XRT LCR — ND 87 
2 EAC 77 F T1N0 No No No S LTBR — ND 44 
3 EAC 74 F T1N0 No No No S+XRT LCR — ND 38 
             
4 EAC 49 M T2N0 No No No S+XRT LTBR — ND 30 
5 EAC 55 F T2N0 No No No S+XRT LTBR — DOD 17 
             
6 EAC 69 M T3N0 Yes No No S+XRT LTBR — ND 65 
7 EAC 63 M T3N0 Yes No No S+XRT LTBR — ND 33 
8 EAC 70 M T3N0 Yes No No S+XRT LTBR + DOD 28 
             
9 ME 72 F T4N0 Yes Yes No S STBR — ND 60 
10 EAC 39 M T4N0 No Yes No S+XRT LTBR — ND 47 
11 EAC 50 F T4N0 No Yes No S+XRT LTBR — ND 32 
12 EAC 60 F T4N1 Yes Yes No S+XRT LTBR + DOD 21 
13 EAC 41 F T4N0 Yes No No S+XRT LTBR + DOD 13 
14 ME 83 F T4N0 Yes No Yes XRT —  DOD 12 
15 ME  65 M T4N0 Yes No Yes XRT —  DOD 12 
16 EAC 78 F T4N0 Yes No Yes XRT —  DOD 8 
EAC, external auditory canal; ME, middle ear; S, Surgery; XRT. Radiation therapy; LTBR, lateral temporal bone resection; LCR, Local canal resection;  
STBR, subtotal temporal bone resection; ND, no disease; DOD, dead of disease  
Extensive bone involvement: all T3 and T4 bone diseases, Extensive soft tissue involvement: T4 soft tissue disease 
Figure 1: Otalgia



















Figure 2: Hearing Disturbance
Negative (n=6)
Positive (n=10)
Figure 3: Extensive Bone Involvement











Figure 4: Extensive Soft Tissue Involvement
Negative (n=12)
Positive (n=4)









Figure 5: Early vs Advanced
Early (n=5)
Advanced (n=11)










Insufficient / no surgery (n=6)










Figure 6: Complete tumor removal 
vs Insufficient / no surgery
